| Evolution of diagnostic criteria for primary aldosteronism: why is it more common in "drug-resistant" hypertension today? | |
| | |
MedLine Citation:
|
PMID: 15527695 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The recent "epidemic" of primary aldosteronism reported in the literature is most likely related to the widespread acceptance that with easy access to accurate measurements of renin and aldosterone, it is no longer necessary to wait until hypokalemia has become profound before embarking on diagnostic testing to attempt to ferret out this most common cause of "essential" hypertension. This is especially true for those who are now classified as "drug resistant" using today's popular drugs, which are particularly ineffective in lowering blood pressure in primary aldosteronism and its variants. Understanding the physiologic consequences of a slowly increasing aldosterone production by autonomous cells will help both the family practitioner and the specialist understand the role of the aldosterone renin ratio (ARR) in the care of the hypertensive patient. In addition, the increasing number of specific genetic mutations that drive sodium retention and lead to low levels of renin activity and familial hypertension must be incorporated into the routine evaluation and care of hypertensive patients and their families. |
| | |
Authors:
|
Clarence E Grim |
Related Documents
:
|
22240915 - Levosimendan attenuates hypoxia-induced pulmonary hypertension in a porcine model. 6378465 - Acute effects of cold on blood pressure, renin-angiotensin-aldosterone system, catechol... 7894215 - Evidence for cardiovascular remodeling in a patient with bartter's syndrome. 2174685 - Vasoactive hormones during hemodialysis with intermittent ultrafiltration. 21056525 - Effects of arterial oxygen content on oxidative stress during resuscitation in a rat he... 11557615 - Effect of nicotine on vasoconstrictor and vasodilator responses in human skin vasculature. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Current hypertension reports Volume: 6 ISSN: 1522-6417 ISO Abbreviation: Curr. Hypertens. Rep. Publication Date: 2004 Dec |
Date Detail:
|
Created Date: 2004-11-05 Completed Date: 2005-02-03 Revised Date: 2006-07-12 |
Medline Journal Info:
|
Nlm Unique ID: 100888982 Medline TA: Curr Hypertens Rep Country: United States |
Other Details:
|
Languages: eng Pagination: 485-92 Citation Subset: IM |
Affiliation:
|
Shared Care Research, Education and Consulting, Inc., 2821 N. 4th Street, Suite 410, Department 71, Milwaukee, WI 53212, USA. lowerbp2@aol.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antihypertensive Agents
/
therapeutic use Drug Resistance Humans Hyperaldosteronism / blood, complications, diagnosis* Hypertension / complications*, drug therapy |
| Chemical | |
Reg. No./Substance:
|
0/Antihypertensive Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Pheochromocytoma: diagnosis and management update.
Next Document: Glucocorticoid excess and hypertension.